Latest Asx Disclosures News

Kinetiko Energy has secured approval to trade on the North American OTCQB Market, aiming to boost investor access and liquidity as it advances its South African gas projects.

Wellard Limited's shares have been suspended from trading on the ASX as the company moves toward official delisting, marking a significant shift for investors and the livestock export sector.

NEXTDC has responded to ASX concerns over early media disclosures about its $7 billion OpenAI data centre deal, affirming compliance with continuous disclosure rules and downplaying price sensitivity.

C29 Metals has explained a delayed filing of a director interest notice as an isolated administrative oversight, reaffirming its compliance policies.

Cauldron Energy’s CEO posted a video during a trading halt that prematurely hinted at exploration results, breaching ASX disclosure rules. The company acknowledges the misstep and outlines steps to tighten compliance.

Sequoia Financial Group has acknowledged that ASIC’s civil penalty proceedings against its subsidiary InterPrac are material and confirmed timely disclosure to the market following formal notification.

Zoono Group Limited has clarified the recent spike in its share price and trading volume, linking it to a new South African packaging agreement and a freshly announced contract with Multisteps Pty Ltd.

Resolution Minerals has clarified its compliance with ASX disclosure rules following a $2 million placement to Tribeca Investment Partners, confirming the transaction's material impact on its share price.

NT Minerals has disclosed the termination of discussions over a potential share sale agreement following unusual trading activity in its securities. The company confirms compliance with ASX disclosure rules after responding to an ASX query.

ASF Group’s subsidiary has secured AUSTRAC registration as a Digital Currency Exchange, positioning itself for future digital asset opportunities while holding off on active trading.

OncoSil Medical Limited has addressed ASX concerns over delayed disclosure of PANCOSIL clinical trial results, confirming compliance with continuous disclosure obligations despite procedural oversights.

AUB Group Limited has disclosed a conditional, non-binding proposal from an EQT affiliate to acquire the company at $45 per share, following unusual trading activity and media reports.